COMMUNIQUÉS West-GlobeNewswire

Agios to Present Updated Clinical Data at the 2018 ASH Annual Meeting
01/11/2018
– Updated Single Agent Ivosidenib Data in Previously Untreated Acute Myeloid Leukemia (AML) Patients from Phase 1 Study Chosen for Oral Presentation – – Updated Data from Phase 1 Frontline AML Combination Study of [...]
Sunesis Pharmaceuticals Announces Presentations at 60th American Society of Hematology Annual Meeting
01/11/2018
SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Sunesis Pharmaceuticals, Inc. (Nasdaq: SNSS) today announced two poster presentations and an oral presentation at the 60 th American Society of Hematology ( [...]
Affimed Announces Oral Presentation and Five Poster Presentations at the 2018 American Society of Hematology Annual Meeting
01/11/2018
Heidelberg, Germany, November 1, 2018 - Affimed N.V. (Nasdaq: AFMD), a clinical stage biopharmaceutical company focused on discovering and developing highly targeted cancer immunotherapies that harness the power of [...]
Genmab Announces Data to be Presented at 2018 ASH Annual Meeting
01/11/2018
Media Release Thirty-five total abstracts on Genmab owned and partnered programs scheduled for presentation at ASH Three abstracts related to Genmab owned programs: DuoBody ® -CD3xCD20 & DuoHexaBody™-CD37 [...]
Precipio and PerkinElmer Collaborate to Provide Solutions for Liquid Biopsy Testing Workflows
01/11/2018
Precipio ICE COLD-PCR™ reagents will be sold with PerkinElmer DNA/RNA extraction and isolation products NEW HAVEN, Conn., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. ( NASDAQ: [...]
argenx announces new cusatuzumab (ARGX-110) AML data in abstracts published in connection with 60th American Society of Hematology Annual Meeting and Exposition
01/11/2018
Regulated information – Inside information 92% overall response rate with durability up to 14.4 months in ongoing analysis of Phase 1/2 trial Updated results from Phase 1/2 trial of cusatuzumab in CTCL also published [...]
Bio-Path Holdings to Present Clinical Data at the 60th Annual American Society of Hematology Annual Meeting
01/11/2018
HOUSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Bio-Path Holdings, Inc., (NASDAQ: BPTH), a biotechnology company leveraging its proprietary DNAbilize ® antisense RNAi nanoparticle technology to develop a portfolio of [...]
Unum Therapeutics to Present Preliminary Results from Ongoing Phase 1 Studies ATTCK-20-03 and ATTCK-17-01 at the 2018 ASH Annual Meeting
01/11/2018
CAMBRIDGE, Mass., Nov. 01, 2018 (GLOBE NEWSWIRE) -- Unum Therapeutics Inc. (NASDAQ: UMRX), a clinical-stage biopharmaceutical company focused on the development of cellular immunotherapies based on its novel, universal [...]
Bellicum Announces Data Presentations on Lead Product Candidate Rivo-cel and Controllable CAR Program at the 60th American Society of Hematology Annual Meeting
01/11/2018
Nine abstracts accepted, including two oral presentations HOUSTON, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM), a leader in developing novel, controllable cellular immunotherapies for [...]
BeiGene to Present Clinical Data on Tislelizumab and Zanubrutinib at the 60th American Society of Hematology Annual Meeting
01/11/2018
Company to Host Investor Meeting and Webcast on Monday, December 3, at 8 pm PST CAMBRIDGE, Mass. and BEIJING, China, Nov. 01, 2018 (GLOBE NEWSWIRE) -- BeiGene, Ltd. (NASDAQ: BGNE), a commercial-stage biopharmaceutical [...]
Progressive Care Inc. CEO to Speak at 5th Annual Florida Telehealth Summit in St. Pete Beach, Florida
01/11/2018
MIAMI, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced that the company will be attending and speaking at the 5th [...]
Konica Minolta Provides New Insights with AeroRemote® Insights
01/11/2018
WAYNE, N.J., Nov. 01, 2018 (GLOBE NEWSWIRE) -- At RSNA 2018, Konica Minolta Healthcare Americas, Inc. will showcase new advancements of the AeroRemote platform. AeroRemote Insights is a comprehensive performance [...]
Forty Seven Inc. to Present New Preclinical Data on 5F9 at the 60th American Society of Hematology (ASH) Annual Meeting
01/11/2018
-- 5F9 Priming Dose Results in CD47 Pruning, Removing CD47 from Surface of Red Blood Cells to Mitigate Risk of Anemia -- -- 5F9 Demonstrates Synergy in Combination with Azacitidine in Acute Myeloid Leukemia (AML) Models [...]
Kura Oncology Announces Upcoming Presentations at ASH Annual Meeting
01/11/2018
SAN DIEGO, Nov. 01, 2018 (GLOBE NEWSWIRE) -- Kura Oncology, Inc. (Nasdaq: KURA), a clinical-stage biopharmaceutical company focused on the development of precision medicines for oncology, today announced that two [...]
Miragen Therapeutics to Present New Cobomarsen Phase 1 Clinical Trial Data at the 2018 American Society of Hematology Annual Meeting
01/11/2018
BOULDER, Colo., Nov. 01, 2018 (GLOBE NEWSWIRE) -- miRagen Therapeutics, Inc. (NASDAQ: MGEN), a clinical-stage biopharmaceutical company focused on the discovery and development of RNA-targeted therapies, today announced [...]
Plus Products: Top-Ranked Edibles in California -- CFN Media
01/11/2018
SEATTLE, Nov. 01, 2018 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- CFN Media Group (“CFN Media”), the leading agency and financial media network dedicated to the North American cannabis industry, announces publication of an [...]
ATW Tech Closes the Sale of its Atman Assets for $1.3 Million
01/11/2018
MONTREAL, Nov. 01, 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (TSX-V: ATW) announces today the closing of the sale of its Psychometric Research and Services of Atman assets (“Atman”), previously announced on September 17, [...]
ATW Tech conclut la vente des actifs d’Atman pour 1,3 million
01/11/2018
MONTRÉAL, 01 nov. 2018 (GLOBE NEWSWIRE) -- ATW Tech Inc. (la « Société » ou « ATW Tech ») (TSX-V : ATW) annonce aujourd’hui la clôture de la vente de ses actifs des Services et Recherche Psychométrique d‘Atman (« Atman [...]
GBT Announces Upcoming Data Presentations at 60th American Society of Hematology (ASH) Annual Meeting & Exposition
01/11/2018
Company to Present Three Oral Presentations, Including Results Beyond 12 Weeks from Part A of the HOPE Study Company to Host Investor Webcast on Monday, December 3 SOUTH SAN FRANCISCO, Calif., Nov. 01, 2018 (GLOBE [...]

Pages